Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Research Foundation’s Incoming President Shares Vision for Building the Next 30 Years of Growth

From the College  |  Issue: December 2015  |  December 15, 2015

Calvin Brown Jr., MD, received funding from the Foundation to help train the next generation of rheumatology professionals.

Calvin Brown Jr., MD, received funding from the Foundation to help train the next generation of rheumatology professionals.

Meet the Foundation’s incoming president, Eric L. Matteson, MD, MPH. Dr. Matteson trained in rheumatology at the University of Michigan and Mayo Graduate School of Medicine, Mayo Clinic College of Medicine. He later earned his Master of Public Health in epidemiology at the University of North Carolina, Chapel Hill. Dr. Matteson currently works as the rheumatology chair at Mayo Clinic in Minnesota. His research interests include epidemiology and novel treatments of vasculitis and rheumatoid arthritis, as well as the impact of rheumatoid arthritis on the development of coexisting conditions, such as heart disease. Following is an excerpt of an interview the Foundation conducted with Dr. Matteson as part of the organization’s 30th anniversary celebration. He reflects on his relationship with the Foundation and his plans for his tenure as president.

Q. How has the Foundation affected your career?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A. In terms of how the Foundation has affected me, there is a global perspective and a personal perspective. Globally, I’m very committed as a rheumatologist and physician [to] taking care of patients [and] advancing the understanding of our diseases. As the biggest private supporter of rheumatology research in the U.S., everything the Foundation does serves that end and helps me help my patients.

The other, more personal, side is that I am co-recipient of a grant that is now fully in the hands of one of my colleagues due to my role in the Foundation. The grant has allowed us to examine lung disease in rheumatoid arthritis (RA), which is one of the major poorly understood comorbidities affecting patients. It’s difficult to find funding to study these topics, and the Foundation has the vision and the resources for us to undertake this project.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Matteson

We are a lot closer [to a cure now] than we were 30 years ago when the Foundation started its work.

Q. How did you first get involved with the Foundation?

A. I first heard about the Foundation when I joined the ACR as a fellow, nearly 30 years ago in 1986. At that time, the Foundation was just getting off the ground. I didn’t know much about it until I got more into my career and got involved with the American College of Rheumatology. I realized the efforts of the Foundation were critical to the success of our workforce development and our research. As rheumatology chair at Mayo Clinic, I look for funding opportunities for our staff—junior staff in particular—to help them with career development and foster the development of workforce in rheumatology. These are things that the Foundation provides resources and infrastructure for. This realization that we are not going to be able to fund or support all of our research and workforce development through the federal government, but rather increasingly need to be knowledgeable about and rely on efforts of the Foundation [and others], got me very engaged with the mission of the Foundation.

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeResearch Rheum Tagged with:ACR/ARHPAssociation of Rheumatology Professionals (ARP)Eric MattesonrheumatologyRheumatology Research Foundation

Related Articles

    Rheum After 5: Dr. Eric Matteson Writes Rheumatic Disease History

    August 12, 2020

    Over the past 20 years, Eric L. Matteson, MD, MPH, emeritus chair, Division of Rheumatology, and emeritus professor of medicine at the Mayo Clinic College of Medicine and Science, Rochester, Minn., as well as a past president of the Rheumatology Research Foundation, has authored or co-authored six books about the history of rheumatic disease and…

    Kussmaul, Meier & Polyarteritis Nodosa

    April 26, 2018

    In 1866, Adolf Kussmaul, an internist, and Rudolf Maier, a pathologist, published the classic characterization of what eventually became known as polyarteritis nodosa.1 It was the first scientific clinical characterization of a noninfectious vasculitis. As such, it became a paradigmatic point of contrast to other types of vasculitides that were later described. Their description also…

    The Tortured Path to the Cortisone Discovery

    February 17, 2019

    CHICAGO—The path to the discovery of cortisone—a top-selling, important drug, with dozens of indications—was complicated by failure, false moves, desperation and obsession. The tale, recounted in the Philip Hench, MD, Memorial Lecture: Crossroads of History & Hope: Discovery & First Use of Cortisone for RA at the 2018 ACR/ARHP Annual Meeting in October, is an…

    The Demise of the Inpatient Rheumatology Unit

    July 19, 2018

    Through much of the 20th century, dedicated rheumatic disease units were found in hospitals across the U.S. and countries around the world. In the latter part of the century, this began to change, with hospitals moving toward the consult model of care for rheumatic patients. This change reflects larger shifts in the medical world toward…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences